Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
perflutren (ImaRx Therapeutics, Inc.)
- Development stage
- Unknown
- Lead developer
- ImaRx Therapeutics
- Modality
- Small Molecules
- Administration
- Intravenous
01
Overview
Definity (perflutren lipid microsphere) is an ultrasound contrast agent (microbubble agent) developed by ImaRx and marketed by Lantheus. It consists of lipid microspheres encapsulating perflutren, a perfluorocarbon gas. When administered intravenously, these microbubbles enhance the echogenicity of blood, improving the visualization of vascular structures and tissue perfusion during ultrasound imaging. Definity is FDA-approved as an echocardiographic contrast agent for cardiac imaging (left ventricular opacification and endocardial border delineation) in both adult and pediatric patients. It has also been investigated for other diagnostic applications, including the characterization of thyroid nodules using contrast-enhanced ultrasound (CEUS).
- Brand names
- DefinityDefinity RTLuminity
- Other names
- octafluoropropaneoctafluoropropane-lipid microsphereperflutren lipid microsphereperflutren lipid microspheres
Beyond the preview
Go deeper on perflutren (ImaRx Therapeutics, Inc.).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on perflutren (ImaRx Therapeutics, Inc.).